Notice of Draft NIJ Law Enforcement Duty Holster Selection and Application Guide, 69458-69459 [2010-28431]

Download as PDF 69458 Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices Secs. 1, 2, and 3; Secs. 10 to 15, inclusive; Secs. 22 to 27, inclusive. Containing approximately 9,210 acres. T. 38 S., R. 53 W., Secs. 1, 12, 13, and 24. Containing approximately 2,560 acres. T. 39 S., R. 53 W., Secs. 34, 35, and 36. Containing approximately 1,920 acres. T. 40 S., R. 53 W., Secs. 1 to 19, inclusive; Secs. 21 to 28, inclusive; Sec. 36. Containing approximately 17,896 acres. T. 41 S., R. 53 W., Secs. 1, 4, and 9; Secs. 11, 12, and 16. Containing approximately 3,840 acres. T. 40 S., R. 54 W., Secs. 7 to 34, inclusive. Containing approximately 17,901 acres. Aggregating approximately 146,693 acres. Notice of the decision will also be published four times in the Kodiak Daily Mirror. Eileen Ford, Land Transfer Resolution Specialist, Land Transfer Adjudication II Branch. [FR Doc. 2010–28433 Filed 11–10–10; 8:45 am] BILLING CODE 4310–JA–P DEPARTMENT OF THE INTERIOR Bureau of Land Management [CACA–048880, LLCAD060000, L51010000.FX0000, LVRWB09B2520] Notice of Availability of the Record of Decision for the Genesis Solar Energy Project and Amendment to the California Desert Conservation Area Resource Management Plan, Riverside County, CA AGENCY: Bureau of Land Management, Interior. ACTION: Notice of availability. The Bureau of Land Management (BLM) announces the availability of the Record of Decision (ROD)/Approved Amendment to the California Desert Conservation Area (CDCA) Plan, the applicable Resource Management Plan (RMP) for the project site and the surrounding areas, located in the California Desert District. The Secretary of the Interior approved the ROD on November 4, 2010, which constitutes the final decision of the Department. ADDRESSES: Copies of the ROD/ Approved Amendment to the CDCA Plan are available upon request from the Field Manager, Palm Springs-South Coast Field Office, Bureau of Land mstockstill on DSKH9S0YB1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:23 Nov 10, 2010 Jkt 223001 Management, 1201 Bird Center Drive, Palm Springs, California 92262 or via the Internet at the following Web site: http://www.blm.gov/ca/st/en/fo/ palmsprings.html. FOR FURTHER INFORMATION CONTACT: Allison Shaffer, BLM Project Manager; telephone: (760) 833–7100; mailing address: 1201 Bird Center Drive, Palm Springs, California 92262; or e-mail: CAPSSolarNextEraFPL@blm.gov. SUPPLEMENTARY INFORMATION: Genesis Solar, LLC, a wholly owned subsidiary of NextEra Energy Resources, filed rightof-way (ROW) application CACA– 048880 for the proposed Genesis Solar Energy Project (GSEP). The GSEP is a concentrated solar electrical generating facility using parabolic trough technology and facilities. The GSEP site is proposed on approximately 1,950 acres of BLM-managed lands in Riverside County, California, approximately 27 miles east of the unincorporated community of Desert Center and 25 miles west of the Arizona-California border city of Blythe. The GSEP consists of 2 independent solar electric generating facilities with a net electrical output of 125 megawatts (MW) each, resulting in a total net electrical output of 250 MW. In addition to the site, the project includes a distribution line, an electrical transmission line, fiber optic lines, a natural gas pipeline, and an access road. A double circuit 230-kilovolt (kV) transmission line will be constructed to connect to the Southern California Edison Colorado River substation via the existing Blythe Energy Project Transmission Line between the Julian Hinds and Buck substations. The linear facilities will encumber approximately 90 acres offsite. The project site is in the California Desert District within the planning boundary of the CDCA Plan, which is the applicable RMP for the project site and the surrounding areas. The CDCA Plan, while recognizing the potential compatibility of solar generation facilities on public lands, requires that all sites associated with power generation or transmission not already identified in that Plan be considered through the BLM’s land use plan amendment process. As a result, prior to approval of a ROW grant for the GSEP, the BLM must amend the CDCA Plan to allow the solar generating project on that site. The approved Amendment to the CDCA Plan specifically revises the CDCA Plan to allow for the development of the GSEP and ancillary facilities on land managed by the BLM. The BLM preferred alternative would result in the building of 2 adjacent and PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 independent power block units, capable of generating approximately 250 MW of electricity, and the use of dry cooling technology, as well as all associated ancillary facilities. This 250 MW alternative was evaluated in the Final Environmental Impact Statement (EIS). The Notice of Availability of the Final EIS for the GSEP and the proposed CDCA Plan amendment was published in the Federal Register on August 27, 2010 (75 FR 52736). Publication of the Notice of Availability for the Final EIS initiated a 30-day protest period for the proposed amendment to the CDCA Plan and a 30day comment period on the Final EIS. At the close of the 30-day period on September 27, 2010, 3 timely and complete written protests were received and resolved. Their resolution is summarized in the Director’s Protest Summary Report attached to the ROD. The proposed amendment to the CDCA Plan was not modified as a result of the protest resolution. In addition, the BLM received 10 comment letters on the Final EIS. The BLM’s responses to these comments are provided in Appendix 1 of the ROD. Simultaneously with the protest period, the Governor of California conducted a 30-day consistency review of the proposed CDCA Plan amendment to identify any inconsistencies with the state or local plan, policies, or programs. The California Governor’s office did not identify inconsistencies between the proposed amendment to the CDCA Plan and state or local plan, policies, or programs. Because this decision is approved by the Secretary of the Interior, it is not subject to administrative appeal (43 CFR 4.410(a)(3)). Authority: 40 CFR 1506.6. Robert V. Abbey, Director, Bureau of Land Management. [FR Doc. 2010–28434 Filed 11–10–10; 8:45 am] BILLING CODE 4310–40–P DEPARTMENT OF JUSTICE Office of Justice Programs [OJP (NIJ) Docket No. 1526] Notice of Draft NIJ Law Enforcement Duty Holster Selection and Application Guide National Institute of Justice. Notice of Draft NIJ Law Enforcement Duty Holster Selection and Application Guide. AGENCY: ACTION: In an effort to obtain comments from interested parties, the SUMMARY: E:\FR\FM\12NON1.SGM 12NON1 69459 Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices U.S. Department of Justice, Office of Justice Programs, National Institute of Justice (NIJ) will make available to the general public the draft ‘‘NIJ Law Enforcement Duty Holster Selection and Application Guide.’’ The opportunity to provide comments on this document is open to industry technical representatives, law enforcement agencies and organizations, research, development and scientific communities, and all other stakeholders and interested parties. Those individuals wishing to obtain and provide comments on the draft document under consideration are directed to the following Web site: http://www.justnet.org. DATES: Comments must be received on or before December 13, 2010. FOR FURTHER INFORMATION CONTACT: Vanessa Castellanos, by telephone at 202–514–5272 [Note: This is not a tollfree telephone number], or by e-mail at vanessa.castellanos@usdoj.gov. John H. Laub, Director, National Institute of Justice. [FR Doc. 2010–28431 Filed 11–10–10; 8:45 am] BILLING CODE 4410–18–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on August 26, 2010, Formulation Technologies LLC., 11400 Burnet Road, Suite 4010, Austin, Texas 78758, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Fentanyl (9801), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substance for analytical characterization, secondary packaging, and for distribution to clinical trial sites. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic class of controlled substance may file comments or objections to the issuance of the proposed registration, and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than December 13, 2010. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745–46), all applicants for registration to import a basic class of any controlled substances in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: November 1, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–28527 Filed 11–10–10; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to Title 21 Code of Federal Regulations 1301.34 (a), this is notice that on June 16, 2010, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665–2402, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the basic classes of controlled substances listed in schedule I and II: mstockstill on DSKH9S0YB1PROD with NOTICES Drug Schedule Cathinone (1235) ......................................................................................................................................................................................... Methcathinone (1237) .................................................................................................................................................................................. N–Ethylamphetamine (1475) ....................................................................................................................................................................... N,N–Dimethylamphetamine (1480) ............................................................................................................................................................. Fenethylline (1503) ...................................................................................................................................................................................... Gamma Hydroxybutyric Acid (2010) ........................................................................................................................................................... Ibogaine (7260) ........................................................................................................................................................................................... Lysergic acid diethylamide (7315) ............................................................................................................................................................... 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ............................................................................................................................... Marihuana (7360) ........................................................................................................................................................................................ Tetrahydrocannabinols (7370) ..................................................................................................................................................................... Mescaline (7381) ......................................................................................................................................................................................... 3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. 2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ 3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... 3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ 3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ 4-Methoxyamphetamine (7411) ................................................................................................................................................................... Alpha-methyltryptamine (7432) ................................................................................................................................................................... Diethyltryptamine (7434) ............................................................................................................................................................................. Dimethyltryptamine (7435) .......................................................................................................................................................................... Psilocybin (7437) ......................................................................................................................................................................................... Psilocyn (7438) ............................................................................................................................................................................................ VerDate Mar<15>2010 17:23 Nov 10, 2010 Jkt 223001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\12NON1.SGM 12NON1 I I I I I I I I I I I I I I I I I I I I I I I I I I

Agencies

[Federal Register Volume 75, Number 218 (Friday, November 12, 2010)]
[Notices]
[Pages 69458-69459]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28431]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Office of Justice Programs

[OJP (NIJ) Docket No. 1526]


Notice of Draft NIJ Law Enforcement Duty Holster Selection and 
Application Guide

AGENCY: National Institute of Justice.

ACTION: Notice of Draft NIJ Law Enforcement Duty Holster Selection and 
Application Guide.

-----------------------------------------------------------------------

SUMMARY: In an effort to obtain comments from interested parties, the

[[Page 69459]]

U.S. Department of Justice, Office of Justice Programs, National 
Institute of Justice (NIJ) will make available to the general public 
the draft ``NIJ Law Enforcement Duty Holster Selection and Application 
Guide.'' The opportunity to provide comments on this document is open 
to industry technical representatives, law enforcement agencies and 
organizations, research, development and scientific communities, and 
all other stakeholders and interested parties. Those individuals 
wishing to obtain and provide comments on the draft document under 
consideration are directed to the following Web site: http://www.justnet.org.

DATES: Comments must be received on or before December 13, 2010.

FOR FURTHER INFORMATION CONTACT: Vanessa Castellanos, by telephone at 
202-514-5272 [Note: This is not a toll-free telephone number], or by e-
mail at vanessa.castellanos@usdoj.gov.

John H. Laub,
Director, National Institute of Justice.
[FR Doc. 2010-28431 Filed 11-10-10; 8:45 am]
BILLING CODE 4410-18-P